Microglia and astrocytes mediate synapse engulfment in a MER tyrosine kinase-dependent manner after traumatic brain

Hui Shen1, Xiao-Jing Shi1, Lin Qi1

  • 1Med-X Research Institute and School of Biomedical Engineering, Shanghai Jiao Tong University, Shanghai, China.

Insights

MER proto-oncokinase drives synaptic phagocytosis by microglia/macrophages and astrocytes after traumatic brain injury. Inhibiting this MER pathway offers a potential therapeutic strategy for brain injury recovery.

Area of Science:

  • Neuroscience
  • Immunology
  • Cell Biology

Background:

  • Microglia/macrophages and astrocytes mediate synaptic phagocytosis via MER proto-oncokinase in development and stroke.
  • The role of MER proto-oncokinase in synaptic phagocytosis following traumatic brain injury (TBI) remains unexplored.

Purpose of the Study:

  • To investigate the involvement of MER proto-oncokinase in synaptic phagocytosis in a mouse model of TBI.
  • To evaluate the therapeutic potential of inhibiting MER-mediated synaptic phagocytosis for TBI treatment.

Main Methods:

  • Establishment of a mouse model of traumatic brain injury.
  • Analysis of MER proto-oncokinase expression in microglia/macrophages and astrocytes post-TBI.
  • Generation of microglia/macrophage-specific and astrocyte-specific MER knock-out mouse lines.
  • Assessment of injury volume, neurobehavioral function, synaptic phagocytosis, and dendritic spine density.

Main Results:

  • Both microglia/macrophages and astrocytes phagocytosed synapses in the TBI model, with increased MER proto-oncokinase expression 14 days post-injury.
  • Specific knockout of MER in microglia/macrophages or astrocytes significantly reduced TBI volume and improved neurobehavioral outcomes.
  • MER knockout models showed decreased synaptic phagocytosis by these glial cells and increased dendritic spine density.

Conclusions:

  • MER proto-oncokinase plays a critical role in mediating synaptic phagocytosis by microglia/macrophages and astrocytes after TBI.
  • Inhibiting MER-mediated synaptic phagocytosis presents a promising novel therapeutic strategy for managing traumatic brain injury.